Fundz

Vizgen Announces $85.2 Million Series C Financing

PRIVATEJun 03, 2022

Amount Raised

$85.2 Million

Round Type

Series C

CambridgeBiotechnology

Description

Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced the closing of $85.2 million Series C financing. The financing was led by Blue Water Life Science Advisors and ARCH Venture Partners. Also participating in the round were new and existing investors Sofina, Northpond Ventures, Tao Capital Partners, Novalis LifeSciences, David Walt, and others.

Quick answer

Vizgen raised $85.2 Million in a Series C round, dated June 3, 2022. Vizgen is based in Cambridge, Massachusetts, United States.

How much did Vizgen raise?
Vizgen raised $85.2 Million in a Series C round on June 3, 2022.
What does Vizgen do?
Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single cell spatial genomics, setting the standard for the spatial genomics field.
Where is Vizgen based and how big is it?
Vizgen is based in Cambridge, Massachusetts, United States. Fundz records about 131 employees.
Who are the decision-makers at Vizgen?
Fundz holds 2 contacts at Vizgen. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Vizgen that raised within 45 days of this round, from Fundz verified event records.

  • i2O Therapeutics, Inc. raised $34M on July 18, 2022.
  • IMAGINE PHARMA LLC raised $50K (Seed) on July 18, 2022.
  • DELFI Diagnostics raised $225M (Series B) on July 18, 2022.
  • MatriSys Bioscience raised $8.4M on July 15, 2022.
  • Entero Therapeutics raised $300K (Seed) on July 15, 2022.
  • Gossamer Bio raised $120M on July 15, 2022.

Who to call at Vizgen, and when

A new round usually means Vizgen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vizgen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vizgen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vizgen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vizgen

Location

150 Bear Hill Road

Cambridge, Massachusetts, United States

About

Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single cell spatial genomics, setting the standard for the spatial genomics field. These tools are enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context. The company's MERSCOPE Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivaled detection efficiency at subcellular resolution. MERSCOPE provides transformative insight into a wide range of tissue-scale basic research and translational medicine in oncology, immunology, neuroscience, infectious disease, developmental biology, cell and gene therapy, and is an essential tool for accelerating drug discovery and development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vizgen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts9 people are listed at Vizgen. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vizgen's next move

See what Strategic adds

Vizgen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.